{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:34:13Z","timestamp":1782902053683,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00392-022-02148-2","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T16:02:41Z","timestamp":1672675361000},"page":"1044-1055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Cardiovascular and renal effects of SGLT2 inhibitor initiation in acute heart failure: a meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0918-6759","authenticated-orcid":false,"given":"Pedro E. P.","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago M. A.","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Sim\u00f5es e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Gewehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline S.","family":"Dagostin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Nasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhanderson","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,2]]},"reference":[{"key":"2148_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/S41572-020-0151-7","author":"M Arrigo","year":"2020","unstructured":"Arrigo M, Jessup M, Mullens W, Reza N, Shah AM, Sliwa K et al (2020) Acute heart failure. Nat Rev Dis Primers. https:\/\/doi.org\/10.1038\/S41572-020-0151-7","journal-title":"Nat Rev Dis Primers"},{"key":"2148_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/J.TCM.2019.03.007","volume":"30","author":"L Sinnenberg","year":"2020","unstructured":"Sinnenberg L, Givertz MM (2020) Acute heart failure. Trends Cardiovasc Med 30:104\u2013112. https:\/\/doi.org\/10.1016\/J.TCM.2019.03.007","journal-title":"Trends Cardiovasc Med"},{"key":"2148_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/J.JCHF.2016.03.024","volume":"4","author":"JM Testani","year":"2016","unstructured":"Testani JM, ter Maaten JM (2016) Decongestion in acute heart failure: does the end justify the means? JACC Heart Fail 4:589\u2013590. https:\/\/doi.org\/10.1016\/J.JCHF.2016.03.024","journal-title":"JACC Heart Fail"},{"key":"2148_CR4","doi-asserted-by":"publisher","first-page":"E895","DOI":"10.1161\/CIR.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al (2022) 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: a Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145:E895-1032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063","journal-title":"Circulation"},{"key":"2148_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/J.IJCARD.2018.01.067","volume":"258","author":"J Rubio-Gracia","year":"2018","unstructured":"Rubio-Gracia J, Demissei BG, ter Maaten JM, Cleland JG, O\u2019Connor CM, Metra M et al (2018) Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. Int J Cardiol 258:185\u2013191. https:\/\/doi.org\/10.1016\/J.IJCARD.2018.01.067","journal-title":"Int J Cardiol"},{"key":"2148_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1161\/CIRCHEARTFAILURE.114.001957","volume":"8","author":"A Lala","year":"2015","unstructured":"Lala A, McNulty SE, Mentz RJ, Dunlay SM, Vader JM, AbouEzzeddine OF et al (2015) Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Circ Heart Fail 8:741\u2013748. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001957","journal-title":"Circ Heart Fail"},{"key":"2148_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1161\/CIRCHEARTFAILURE.108.821785","volume":"2","author":"GM Felker","year":"2009","unstructured":"Felker GM, O\u2019Connor CM, Braunwald E (2009) Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? Circ Heart Fail 2:56\u201362. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.108.821785","journal-title":"Circ Heart Fail"},{"key":"2148_CR8","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1016\/S2214-109X(20)30004-8\/ATTACHMENT\/1802E068-4F97-416B-9C39-478CB776A7F6\/MMC1.PDF","volume":"8","author":"J Tromp","year":"2020","unstructured":"Tromp J, Bamadhaj S, Cleland JGF, Angermann CE, Dahlstrom U, Ouwerkerk W et al (2020) Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. Lancet Glob Health 8:e411\u2013e422. https:\/\/doi.org\/10.1016\/S2214-109X(20)30004-8\/ATTACHMENT\/1802E068-4F97-416B-9C39-478CB776A7F6\/MMC1.PDF","journal-title":"Lancet Glob Health"},{"key":"2148_CR9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/S00134-010-2113-0","volume":"37","author":"F Follath","year":"2011","unstructured":"Follath F, Yilmaz MB, Delgado JF, Parissis JT, Porcher R, Gayat E et al (2011) Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF). Intensive Care Med 37:619\u2013626. https:\/\/doi.org\/10.1007\/S00134-010-2113-0","journal-title":"Intensive Care Med"},{"key":"2148_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/JAMA.2012.216476","volume":"309","author":"K Dharmarajan","year":"2013","unstructured":"Dharmarajan K, Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI et al (2013) Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA 309:355\u2013363. https:\/\/doi.org\/10.1001\/JAMA.2012.216476","journal-title":"JAMA"},{"key":"2148_CR11","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/EJHF.1492","volume":"21","author":"O Chioncel","year":"2019","unstructured":"Chioncel O, Mebazaa A, Maggioni AP, Harjola VP, Rosano G, Laroche C et al (2019) Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry. Eur J Heart Fail 21:1338\u20131352. https:\/\/doi.org\/10.1002\/EJHF.1492","journal-title":"Eur J Heart Fail"},{"key":"2148_CR12","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1001\/JAMA.2010.748","volume":"303","author":"H Bueno","year":"2010","unstructured":"Bueno H, Ross JS, Wang Y, Chen J, Vid\u00e1n MT, Normand SLT et al (2010) Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993\u20132006. JAMA 303:2141\u20132147. https:\/\/doi.org\/10.1001\/JAMA.2010.748","journal-title":"JAMA"},{"key":"2148_CR13","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/EJHF.283","volume":"17","author":"S Harikrishnan","year":"2015","unstructured":"Harikrishnan S, Sanjay G, Anees T, Viswanathan S, Vijayaraghavan G, Bahuleyan CG et al (2015) Clinical presentation, management, in-hospital and 90-day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum Heart Failure Registry. Eur J Heart Fail 17:794\u2013800. https:\/\/doi.org\/10.1002\/EJHF.283","journal-title":"Eur J Heart Fail"},{"key":"2148_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/S10741-019-09912-Z","volume":"26","author":"AM Altibi","year":"2021","unstructured":"Altibi AM, Prousi G, Agarwal M, Shah M, Tripathi B, Ram P et al (2021) Readmission-free period and in-hospital mortality at the time of first readmission in acute heart failure patients-NRD-based analysis of 40,000 heart failure readmissions. Heart Fail Rev 26:57\u201364. https:\/\/doi.org\/10.1007\/S10741-019-09912-Z","journal-title":"Heart Fail Rev"},{"key":"2148_CR15","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMOA1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381:1995\u20132008. https:\/\/doi.org\/10.1056\/NEJMOA1911303","journal-title":"N Engl J Med"},{"key":"2148_CR16","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMOA2022190\/SUPPL_FILE\/NEJMOA2022190_DATA-SHARING.PDF","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P et al (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383:1413\u20131424. https:\/\/doi.org\/10.1056\/NEJMOA2022190\/SUPPL_FILE\/NEJMOA2022190_DATA-SHARING.PDF","journal-title":"N Engl J Med"},{"key":"2148_CR17","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMOA2107038\/SUPPL_FILE\/NEJMOA2107038_DATA-SHARING.PDF","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, B\u00f6hm M et al (2021) Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 385:1451\u20131461. https:\/\/doi.org\/10.1056\/NEJMOA2107038\/SUPPL_FILE\/NEJMOA2107038_DATA-SHARING.PDF","journal-title":"N Engl J Med"},{"key":"2148_CR18","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMOA2024816\/SUPPL_FILE\/NEJMOA2024816_DATA-SHARING.PDF","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stef\u00e1nsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou F-F et al (2020) Dapagliflozin in patients with chronic kidney disease. N Engl J Med 383:1436\u20131446. https:\/\/doi.org\/10.1056\/NEJMOA2024816\/SUPPL_FILE\/NEJMOA2024816_DATA-SHARING.PDF","journal-title":"N Engl J Med"},{"key":"2148_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/S12933-022-01455-2","author":"HM Salah","year":"2022","unstructured":"Salah HM, Al\u2019Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL et al (2022) Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis. Cardiovasc Diabetol. https:\/\/doi.org\/10.1186\/S12933-022-01455-2","journal-title":"Cardiovasc Diabetol"},{"key":"2148_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/BMJ.N71","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, The PRISMA et al (2020) statement: an updated guideline for reporting systematic reviews. BMJ 2021:372. https:\/\/doi.org\/10.1136\/BMJ.N71","journal-title":"BMJ"},{"key":"2148_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.L4898","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. https:\/\/doi.org\/10.1136\/BMJ.L4898","journal-title":"BMJ"},{"key":"2148_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/OPENHRT-2021-001936","volume":"9","author":"K Charaya","year":"2022","unstructured":"Charaya K, Shchekochikhin D, Andreev D, Dyachuk I, Tarasenko S, Poltavskaya M et al (2022) Impact of dapagliflozin treatment on renal function and diuretics use in acute heart failure: a pilot study. Open Heart 9:e001936. https:\/\/doi.org\/10.1136\/OPENHRT-2021-001936","journal-title":"Open Heart"},{"key":"2148_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/J.JACC.2022.07.021","author":"JW Cunningham","year":"2022","unstructured":"Cunningham JW, Vaduganathan M, Claggett BL, Kulac IJ, Desai AS, Jhund PS et al (2022) Dapagliflozin in patients recently hospitalized with heart failure and mildly reduced or preserved ejection fraction. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/J.JACC.2022.07.021","journal-title":"J Am Coll Cardiol"},{"key":"2148_CR24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/EJHF.1713","volume":"22","author":"K Damman","year":"2020","unstructured":"Damman K, Beusekamp JC, Boorsma EM, Swart HP, Smilde TDJ, Elvan A et al (2020) Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF). Eur J Heart Fail 22:713\u2013722. https:\/\/doi.org\/10.1002\/EJHF.1713","journal-title":"Eur J Heart Fail"},{"key":"2148_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/EJHF.2066","volume":"23","author":"EM Boorsma","year":"2021","unstructured":"Boorsma EM, Beusekamp JC, ter Maaten JM, Figarska SM, Danser AHJ, van Veldhuisen DJ et al (2021) Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure. Eur J Heart Fail 23:68\u201378. https:\/\/doi.org\/10.1002\/EJHF.2066","journal-title":"Eur J Heart Fail"},{"key":"2148_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.059038","author":"PC Schulze","year":"2022","unstructured":"Schulze PC, Bogoviku J, Westphal J, Aftanski P, Haertel F, Grund S et al (2022) Effects of early empagliflozin initiation on diuresis and kidney function in patients with acute decompensated heart failure (EMPAG-HF). Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.059038","journal-title":"Circulation"},{"key":"2148_CR27","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/S41591-021-01659-1","volume":"28","author":"AA Voors","year":"2022","unstructured":"Voors AA, Angermann CE, Teerlink JR, Collins SP, Kosiborod M, Biegus J et al (2022) The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nat Med 28:568\u2013574. https:\/\/doi.org\/10.1038\/S41591-021-01659-1","journal-title":"Nat Med"},{"key":"2148_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/FCVM.2020.602251","author":"A Ibrahim","year":"2020","unstructured":"Ibrahim A, Ghaleb R, Mansour H, Hanafy A, Mahmoud NM, Elsharef MA et al (2020) Safety and efficacy of adding dapagliflozin to furosemide in type 2 diabetic patients with decompensated heart failure and reduced ejection fraction. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/FCVM.2020.602251","journal-title":"Front Cardiovasc Med"},{"key":"2148_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMOA2030183\/SUPPL_FILE\/NEJMOA2030183_DATA-SHARING.PDF","volume":"384","author":"DL Bhatt","year":"2021","unstructured":"Bhatt DL, Szarek M, Steg PG, Cannon CP, Leiter LA, McGuire DK et al (2021) Sotagliflozin in patients with diabetes and recent worsening heart failure. N Engl J Med 384:117\u2013128. https:\/\/doi.org\/10.1056\/NEJMOA2030183\/SUPPL_FILE\/NEJMOA2030183_DATA-SHARING.PDF","journal-title":"N Engl J Med"},{"key":"2148_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1161\/CIRCHEARTFAILURE.120.007048","volume":"14","author":"S Tamaki","year":"2021","unstructured":"Tamaki S, Yamada T, Watanabe T, Morita T, Furukawa Y, Kawasaki M et al (2021) Effect of empagliflozin as an add-on therapy on decongestion and renal function in patients with diabetes hospitalized for acute decompensated heart failure: a prospective randomized controlled study. Circ Heart Fail 14:327\u2013338. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.007048","journal-title":"Circ Heart Fail"},{"key":"2148_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/EHF2.13955","author":"K Thiele","year":"2022","unstructured":"Thiele K, Rau M, Hartmann NK, M\u00f6ller M, M\u00f6llmann J, Jankowski J et al (2022) Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure. ESC Heart Fail. https:\/\/doi.org\/10.1002\/EHF2.13955","journal-title":"ESC Heart Fail"},{"key":"2148_CR32","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/EURHEARTJ\/EHX035","volume":"38","author":"W Mullens","year":"2017","unstructured":"Mullens W, Verbrugge FH, Nijst P, Tang WHW (2017) Renal sodium avidity in heart failure: from pathophysiology to treatment strategies. Eur Heart J 38:1872\u20131882. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHX035","journal-title":"Eur Heart J"},{"key":"2148_CR33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/ANNUREV-PHYSIOL-031620-095920","volume":"83","author":"V Vallon","year":"2021","unstructured":"Vallon V, Verma S (2021) Effects of SGLT2 inhibitors on kidney and cardiovascular function. Annu Rev Physiol 83:503\u2013528. https:\/\/doi.org\/10.1146\/ANNUREV-PHYSIOL-031620-095920","journal-title":"Annu Rev Physiol"},{"key":"2148_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/DOM.13126","volume":"20","author":"KM Hallow","year":"2018","unstructured":"Hallow KM, Helmlinger G, Greasley PJ, McMurray JJV, Boulton DW (2018) Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis. Diabetes Obes Metab 20:479\u2013487. https:\/\/doi.org\/10.1111\/DOM.13126","journal-title":"Diabetes Obes Metab"},{"key":"2148_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/J.IJCARD.2017.08.053","volume":"254","author":"S Honda","year":"2018","unstructured":"Honda S, Nagai T, Nishimura K, Nakai M, Honda Y, Nakano H et al (2018) Long-term prognostic significance of urinary sodium concentration in patients with acute heart failure. Int J Cardiol 254:189\u2013194. https:\/\/doi.org\/10.1016\/J.IJCARD.2017.08.053","journal-title":"Int J Cardiol"},{"key":"2148_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/EHJACC\/ZUAA006","volume":"10","author":"G Tersalvi","year":"2021","unstructured":"Tersalvi G, Dauw J, Gasperetti A, Winterton D, Cioffi GM, Scopigni F et al (2021) The value of urinary sodium assessment in acute heart failure. Eur Heart J Acute Cardiovasc Care 10:216\u2013223. https:\/\/doi.org\/10.1093\/EHJACC\/ZUAA006","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2148_CR37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/J.JCHF.2019.01.007","volume":"7","author":"DZ Hodson","year":"2019","unstructured":"Hodson DZ, Griffin M, Mahoney D, Raghavendra P, Ahmad T, Turner J et al (2019) Natriuretic response is highly variable and associated with 6-month survival: insights from the ROSE-AHF trial. JACC Heart Fail 7:383\u2013391. https:\/\/doi.org\/10.1016\/J.JCHF.2019.01.007","journal-title":"JACC Heart Fail"},{"key":"2148_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/EHF2.12368","volume":"6","author":"SP Collins","year":"2019","unstructured":"Collins SP, Jenkins CA, Baughman A, Miller KF, Storrow AB, Han JH et al (2019) Early urine electrolyte patterns in patients with acute heart failure. ESC Heart Fail 6:80\u201388. https:\/\/doi.org\/10.1002\/EHF2.12368","journal-title":"ESC Heart Fail"},{"key":"2148_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/S12872-021-02163-7","author":"M Nakagaito","year":"2021","unstructured":"Nakagaito M, Imamura T, Joho S, Ushijima R, Nakamura M, Kinugawa K (2021) Renoprotective effects of sodium glucose cotransporter 2 inhibitors in type 2 diabetes patients with decompensated heart failure. BMC Cardiovasc Disord. https:\/\/doi.org\/10.1186\/S12872-021-02163-7","journal-title":"BMC Cardiovasc Disord"},{"key":"2148_CR40","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1536\/IHJ.21-022","volume":"62","author":"M Nakagaito","year":"2021","unstructured":"Nakagaito M, Imamura T, Joho S, Ushijima R, Nakamura M, Kinugawa K (2021) Efficacy of continuing SGLT2 inhibitors on outcomes in patients with acute decompensated heart failure. Int Heart J 62:885\u2013890. https:\/\/doi.org\/10.1536\/IHJ.21-022","journal-title":"Int Heart J"},{"key":"2148_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/EJHF.2086","volume":"23","author":"W Mullens","year":"2021","unstructured":"Mullens W, Martens P (2021) Empagliflozin and renal sodium handling: an intriguing smart osmotic diuretic. Eur J Heart Fail 23:79\u201382. https:\/\/doi.org\/10.1002\/EJHF.2086","journal-title":"Eur J Heart Fail"},{"key":"2148_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/EJHF.35","volume":"16","author":"FH Verbrugge","year":"2014","unstructured":"Verbrugge FH, Dupont M, Steels P, Grieten L, Swennen Q, Tang WHW et al (2014) The kidney in congestive heart failure: \u201care natriuresis, sodium, and diuretics really the good, the bad and the ugly?\u201d Eur J Heart Fail 16:133\u2013142. https:\/\/doi.org\/10.1002\/EJHF.35","journal-title":"Eur J Heart Fail"},{"key":"2148_CR43","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/J.JCHF.2020.03.009","volume":"8","author":"W McCallum","year":"2020","unstructured":"McCallum W, Tighiouart H, Testani JM, Griffin M, Konstam MA, Udelson JE et al (2020) Acute kidney function declines in the context of decongestion in acute decompensated heart failure. JACC Heart Fail 8:537\u2013547. https:\/\/doi.org\/10.1016\/J.JCHF.2020.03.009","journal-title":"JACC Heart Fail"},{"key":"2148_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/JCM10030505","volume":"10","author":"E Mart\u00edn","year":"2021","unstructured":"Mart\u00edn E, L\u00f3pez-Aguilera J, Gonz\u00e1lez-Manzanares R, Anguita M, Guti\u00e9rrez G, Luque A et al (2021) Impact of canagliflozin in patients with type 2 diabetes after hospitalization for acute heart failure: a cohort study. J Clin Med 10:1\u201311. https:\/\/doi.org\/10.3390\/JCM10030505","journal-title":"J Clin Med"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02148-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-022-02148-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02148-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:02:07Z","timestamp":1744210927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-022-02148-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,2]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2148"],"URL":"https:\/\/doi.org\/10.1007\/s00392-022-02148-2","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,2]]},"assertion":[{"value":"22 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors report no relationships that could be construed as a conflict of interest. All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Registered in PROSPERO Database (CRD42022351714).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registration"}}]}}